The Wolverine Stack: Complete BPC-157 + TB-500 Guide for Athletes

Why the Stack Works Better Than Either Peptide Alone

The most common question about the Wolverine Stack is whether it is genuinely synergistic or simply additive. The mechanistic answer is unambiguous: BPC-157 and TB-500 operate through non-overlapping pathways targeting different aspects of the same healing process.

BPC-157's contribution: Creates the optimal molecular environment at the injury site. Upregulates VEGF (new capillaries), sensitises GH receptors (amplified anabolic repair), activates FAK-paxillin (directed fibroblast migration), and modulates NO (balanced inflammation). These are all local, site-specific effects.

TB-500's contribution: Regulates actin polymerisation systemically, mobilises bone marrow-derived repair cells into circulation, and accelerates their migration throughout the body via enhanced actin dynamics. These are systemic effects.

Neither peptide does what the other does. BPC-157 cannot mobilise repair cells from bone marrow. TB-500 cannot create the local angiogenic and GH-receptor environment that BPC-157 builds. Together they address the full requirement: supply the workers (TB-500) and prepare the worksite (BPC-157).

Complete Dosage Protocol

Phase 1: Acute Loading (Weeks 1-6)

| Peptide | Dose | Frequency | Site | |---|---|---|---| | BPC-157 | 500mcg | Twice daily | Near injury site | | TB-500 | 5mg | Once daily | Any subcutaneous site |

Morning: BPC-157 500mcg + TB-500 5mg (both at the same session) Evening: BPC-157 500mcg only

Phase 2: Maintenance (Week 7+)

| Peptide | Dose | Frequency | |---|---|---| | BPC-157 | 250mcg | Once daily | | TB-500 | 5mg | Once weekly |

For Chronic/Stubborn Injuries

If an injury has not responded after 6 weeks of loading:

• Extend loading phase to 8-10 weeks before switching to maintenance
• Consider adding GHK-Cu (Copper Peptide) 1-2mg/day for enhanced collagen synthesis
• Consider adding Ipamorelin + CJC-1295 pre-sleep (see below)

Enhanced Stack: Adding GH Optimisation

The most comprehensive recovery protocol in the biohacking community extends the Wolverine Stack with a pre-sleep GH secretagogue component:

Evening additions:

• Ipamorelin 200mcg + CJC-1295 (no DAC) 100mcg, subcutaneous, 30-60 min before sleep, fasted

Rationale: The Wolverine Stack creates the local and systemic repair environment. Ipamorelin + CJC-1295 amplifies growth hormone secretion during sleep — the window when the majority of GH-mediated tissue repair and collagen synthesis occurs. BPC-157's GH receptor sensitisation effect means injured tissue is specifically primed to respond to this elevated GH.

Protocol by Injury Type

Tendon Injuries (Achilles, Rotator Cuff, Patellar)

Tendons are the application with the most animal model evidence for BPC-157. Their poor natural blood supply (the primary limiting factor in tendon healing) is directly addressed by BPC-157's angiogenic mechanism. ^[]

• BPC-157 injection site: As close to the affected tendon as possible (subcutaneous fold overlying the injury)
• TB-500: Any site — systemic effect covers the tendon
• Timeline: Full loading phase (6 weeks) minimum; chronic tendinopathy may require 8-10 weeks

Muscle Tears and Strains

• BPC-157: Subcutaneous near the muscle belly (not directly into the muscle)
• TB-500: Systemic distribution handles muscle effectively; inject abdomen or thigh
• Timeline: Grade 2 strains: 3-4 weeks. Grade 3 tears: 6-8 weeks.

Ligament Sprains (ACL, MCL, Ankle)

• BPC-157 near the joint; TB-500 systemically
• Note: BPC-157 can also be administered orally at 500mcg if deep joint injection is not accessible
• Timeline: 6-8 weeks loading, then maintenance through return to sport

Post-Surgical Recovery

• Begin 2 weeks post-surgery (after primary wound healing is established)
• Full loading phase protocol
• Discuss with surgeon — BPC-157's angiogenic effect may accelerate surgical wound healing as a bonus

Gastrointestinal Issues (BPC-157 alone)

For gut-related applications (IBD, ulcers, leaky gut), TB-500 is not relevant. Use BPC-157 orally at 250-500mcg twice daily, on empty stomach.

Reconstitution Reference

BPC-157 (5mg vial):

• Add 1ml bacteriostatic water = 5000mcg/ml (5mg/ml)
• 500mcg dose = 0.1ml = 10 units on U100 insulin syringe

TB-500 (5mg vial):

• Add 2ml bacteriostatic water = 2.5mg/ml
• 5mg dose = 2ml = one full 2ml syringe

Storage:

• Lyophilised (powder): -20°C freezer, stable for years
• Reconstituted: +4°C refrigerator, use within 4 weeks
• Never freeze reconstituted peptide

COA Verification Checklist

Before using any batch of BPC-157 or TB-500, verify the Certificate of Analysis includes:

• [ ] HPLC purity ≥98%
• [ ] Molecular weight confirmation by mass spectrometry
• [ ] Amino acid sequence verification
• [ ] Endotoxin (LAL) testing — negative
• [ ] Heavy metals panel — below detection threshold
• [ ] Sterility testing — no bacterial growth

Suppliers unwilling to provide current batch-specific COA documentation should not be used for injectable compounds.